American HealthCare Capital is proud to introduce a Negative Pressure Wound Therapy (NPWT) company for sale. The company was founded in 2012. A Negative Wound Therapy (NWPT) System is a comprehensive medical treatment system for serious wounds, which are treated in various Healthcare settings. All products are FDA 510K approved and certified.
This NWPT company has experienced stability in volume, profitability, and client base. Payer sources are 99% private pay and 1% insurance payments. Gross collected revenues have been in the $2.1 – $2.5 million range. They ended 2022 at $2,373,917 with an adjusted EBITDA of $252,250.
The growth potential is quite considerable, as the wound care portion of the healthcare market is valued at $23 billion per year, with annual growth of 5%. NPWT is a $3 billion a year segment. The company is projecting to increase exponentially over the next few years, surpassing $12 million by 2025.
The owner wishes to locate a strategic buyer who will help the company grow. Several equity partners and upper management staff are expected to stay on board post-sale to partner with new owners to continue the overall growth trajectory.
The asking price is $3.9 million. The sellers are seeking a strategic buyer who will help the company grow.
If you would like to learn more, please use the link on the right-hand side of the page to execute our NDA. You will need to copy the Listing Code (Example: TXMC1A) and Listing Title (Example: $1 Million Home Health Agency in Texas) from the summary above to complete the NDA.